Searchable abstracts of presentations at key conferences in endocrinology

ea0090p624 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Changes of Cholesterol and Cardiovascular Risk Before and After Initiation of Statin Therapy

Simon Gyorgy , Regina Castro M. , Caraballo Pedro

Introduction: Cholesterol management is essential to prevent coronary artery disease (CAD) and related complications. Lifestyle changes are first treatment, followed by statin therapy. Multiple studies have shown statins to effectively reduce the risk of cardiovascular complications. LDL cholesterol is the main measure to assess impact of statin therapy. However, CAD risk also depends on other often neglected risk factors. We present preliminary data of the evaluation of the s...

ea0081rc10.2 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Weight changes and all-cause mortality in patients with prediabetes and diabetes

Li Jia , Simon Gyorgy , Castro M. Regina , Caraballo Pedro

Introduction: Weight loss is a cornerstone in the management of prediabetes and diabetes mellitus. The association between weight and all-cause mortality is controversial and even paradoxical. Studies usually assess baseline weight. Studies assessing weight changes over time are limited. We present preliminary results of our attempt to model weight changes in patients with prediabetes and diabetes assessing the relationship with all-cause mortality.Metho...

ea0029p5 | Adrenal cortex | ICEECE2012

Non-radioactive strategies on the diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH - 21OHD).

Coeli F. , Turatti W. , Elias P. , Martinelli C. , Moreira A. , Antonini S. , Castro M.

Introduction: Defects in the pseudogene, CYP21A1P, can be transferred to the functional CYP21A2 gene by recombination and account for approximately 95% of CYP21A2 mutations, leading to CAH-21OHD. We conducted a comprehensive genetic analysis to assess whether Multiplex Ligation dependent Probes Amplification (MLPA) could substitute southern blotting with radioactive probes without compromising reliability of the diagnosis.Patients and Methods: We studied...

ea0029p521 | Diabetes | ICEECE2012

Prevalence of autoimmune diseases in a Type 1 diabetic population

Marcelino M. , Castro S. , Santos A. , Amaral D. , Pina R. , Lopes L.

Background: Patients with type 1 diabetes (T1DM) are known to have a higher risk of developing other autoimmune diseases. The most common associated disorders are thyroid autoimmunity (Graves’ disease or Hashimoto’s thyroiditis) and celiac disease.The aim of this study was to investigate the prevalence of other autoimmune disorders in T1DM patients of our clinic.Methods: We reviewed 269 files of children and adolescents w...

ea0029p789 | Endocrine tumours and neoplasia | ICEECE2012

The pathogenesis of non functioning pituitary adenoma with positive staining for glycoproteins is associated with MEG3/DLK1 underexpression/GSTP1 overexpression and modulated by microRNAs (miRNAs)

Paixao B. , Lima D. , Peitl P. , Dinarte A. , Saggioro F. , Moreira A. , Silva W. , Machado H. , Castro M.

Context: Pathogenesis underlying non functioning pituitary adenoma (NFPA) formation and progression has not been well established. MEG3 is strongly expressed in the normal pituitary (NP) but not in NFPA derived from gonadotroph cells. High GSTP1 gene expression also seems to contribute to gonadotroph adenoma development. Recent reports indicate a role of miRNAs in the pituitary adenoma pathogenesis.Objective: To evaluate the expression of MEG3, DLK1, GST...

ea0029p834 | Endocrine tumours and neoplasia | ICEECE2012

Expression of MAPK7 and CCNL1 in corticotrophinomas and functional analysis of miR-143 and miR-145 in corticotrophic tumoral lineage AtT20

Camargo R. , Paixao B. , Colli L. , Varanda W. , Rodrigues J. , Elias L. , Castro M.

Introduction: miR143 and 145 seem to be involved in the pathogenesis of cortitotrophinomas by modulating the expression of MAPK7 and CCNL1 genes, which protein products are involved in cell proliferation, differentiation, and cell cycle progression. Objective: To analyze the modulation of miR-143 and -145 in the expression of MAPK7 and CCNL1 genes in corticotrophinomas and corticotrophic tumoral lineage (AtT20).Material and Methods: The expression of MAP...

ea0029p865 | Endocrine tumours and neoplasia | ICEECE2012

Non-medullary neuroendocrine carcinoma in the thyroid gland: a case-report

Alvarez-Escola C. , Riveiro Villanueva J. , Fernandez Martinez A. , Nistal M. , Castro A. , Barriuso J.

Introduction: Neuroendocrine lesions in the thyroid gland are uncommon. The differential diagnosis usually includes medullary thyroid carcinoma, paraganglioma and metastases. There are few non-conclusive reports of primary neuroendocrine carcinomas of the thyroid.Clinical case: A 49-year-old woman with a past medical history for familial hypercholesterolemia and right oophorectomy for mature teratoma with struma ovarii, was evaluated for a rapidly growin...

ea0056p1186 | Thyroid cancer | ECE2018

Thyroglossal duct cyst papillary carcinoma: case report and review of literature

Delgado M , Paz J , Linares E , Gonzales J , Lopez R , Ponce A , Cabrera F , Calderon K , Regalado S , Casusol J , Castro M , Reano C , Giles I , Corrales J , Saenz S , Rojas Marialejandra Delgado , Reyes Edgardo Linares , Ibarra Jose Luis Paz

Objective: To report a rare case of papillary thyroid carcinoma (PTC) in a thyroglossal duct cyst (TGDC).Case report: A 34-year-old peruvian male came to our hospital with a complaint of a swelling cervical mass in the anterior central side of the neck, which was growing since 6 months earlier. The patient had no significant past medical, surgical history and was completely asymptomatic. He denied any family history of thyroid disease or history of head ...